Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Authorization Safety Study (PASS) of Post-Marketing Surveillance for Intussusception Following Rotarix™ Introduction Into the Instituto Mexicano Del Seguro Social (IMSS) in Mexico

NCT00595205 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00595205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00595205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Authorization Safety Study (PASS) of Post-Marketing Surveillance for Intussusception Following Rotarix™ Introduction Into the Instituto Mexicano Del Seguro Social (IMSS) in Mexico
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
October 31, 2010
Enrollment
786 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intussusception (is), rotavirus vaccines